Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 Clinicopathologic characteristics of 210 non-small-cell lung cancer patients and 180 colorectal cancer patients

From: Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array

 

Lung cancer

Colorectal cancer

Variables

number (%)

number (%)

Gender

  

    Male

112 (53.3)

94 (52.2)

     Female

98 (46.7)

86 (47.8)

Age (years)

  

     <65

115 (54.8)

85 (47.2)

     ≥65

95 (45.2)

95 (52.8)

Stage (AICC)a

  

      I + II

109 (51.9)

93 (51.7)

     III + IV

101 (48.1)

87 (48.3)

T stage

  

     T1 + T2

149 (70.9)

44 (24.4)

     T3 + T4

61 (29.1)

136 (75.6)

Lymph node metastasis

  

       No

94 (44.8)

93 (51.7)

      Yes

116 (55.2)

87 (48.3)

  1. aAmerican Joint Committee on Cancer.